Michael Giladi† - Infectious Diseases

Author Information

Michael Giladi is an esteemed researcher affiliated with The Bernard Pridan Laboratory for Molecular Biology of Infectious Diseases at the Tel Aviv Sourasky Medical Center in Tel Aviv, Israel. His work primarily focuses on infectious diseases, with significant contributions to the understanding and diagnosis of conditions such as Cat Scratch Disease and Bartonella endocarditis.

Research Contributions

Michael Giladi has made substantial contributions to the field of infectious diseases, particularly in the study of Cat Scratch Disease and Bartonella infections. His research includes the molecular diagnosis of these diseases, the impact of treatments like Isavuconazole on invasive fungal diseases, and the prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels. His work also explores the challenges of diagnosing conditions that mimic other illnesses, such as Bartonella endocarditis presenting as systemic vasculitis.

Aliases

Michael Giladi is also known by several aliases in the academic community, including M Giladi, M. Giladi, Michael Giladi\u2020, and Michal Giladi. These variations may appear in different publications and research contributions.

Publication and Citation Metrics

Metric	Value
Total Citation Count	5907
H-index	39
Total Number of Papers	135

Publications:

Misleading Positive Serology for Cat Scratch Disease following Administration of Intravenous Immunoglobulin

DOI: 10.3390/pathogens11020177

Year: 2022

Molecular Diagnosis of Cat Scratch Disease: a 25-Year Retrospective Comparative Analysis of Various Clinical Specimens and Different PCR Assays

DOI: 10.1128/spectrum.02596-21

Year: 2022

Laboratory Diagnosis of 37 Cases of Bartonella Endocarditis Based on Enzyme Immunoassay and Real-Time PCR

DOI: 10.1128/JCM.02217-20

Year: 2021

A cat’s scratch or a wolf’s bite?

DOI: 10.1177/0961203320939632

Year: 2020

Cat scratch disease presenting as fever of unknown origin is a unique clinical syndrome.

DOI: 10.1093/cid/ciz1137

Year: 2019

B artonella endocarditis masquerading as systemic vasculitis with rapidly progressive glomerulonephritis (aka ‘Löhlein nephritis’)

DOI: 10.1136/bcr-2019-231413

Year: 2019

Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species

DOI: 10.1111/myc.12777

Year: 2018

Cat‐scratch disease: ocular manifestations and treatment outcome

DOI: 10.1111/aos.13684

Year: 2018

The prevalence of Middle East respiratory syndrome coronavirus (MERS‐CoV) antibodies in dromedary camels in Israel

DOI: 10.1111/zph.12482

Year: 2018

Isavuconazole for treatment of rare invasive fungal diseases

DOI: 10.1111/myc.12778

Year: 2018

What Treatments are Available for Ebola?

What Are the Symptoms of These Diseases?

What are the Symptoms of ARDS?

What is Hygiene?

What is Viral Mutation and Why is it Important?

How Do Antiparasitics Work?

Can Artemisinin Be Used for Other Infectious Diseases?

Are There Risks Associated with Imaging?

Why are Some Populations More Vulnerable?

What are the Symptoms?

Partnered Content Networks

Relevant Topics